Details

Autor(en) / Beteiligte

• Targownik, Laura E
• Bernstein, Charles N
• Lakatos, Peter L
• Murthy, Sanjay K
• Benchimol, Eric I
• Bitton, Alain
• Huang, James Guoxian
• Kuenzig, M Ellen
• Jones, Jennifer L
• Kaplan, Gilaad G
• Lee, Kate
• Mukhtar, Mariam S
• Tandon, Parul
• Windsor, Joseph W
• Panaccione, Remo

Titel

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications

Ist Teil von

• Journal of the Canadian Association of Gastroenterology, 2021-11, Vol.4 (Supplement_2), p.S40-S45

Ort / Verlag

US: Oxford University Press

Erscheinungsjahr

2021

Link zum Volltext

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Abstract Inflammatory bowel disease (IBD) is a disease that results from dysregulation of the immune system and frequently requires medications that can affect the immune response to infections; therefore, it was imperative to quickly understand the risk of coronavirus disease 2019 (COVID-19) infection on persons living with IBD and how that risk may be increased by commonly used IBD medications. The IBD research community in Canada and beyond quickly established collaborative efforts to better understand the specific risk posed by COVID-19 on persons with IBD. We learned that IBD itself was not a risk factor for death or serious complications of COVID-19, and that most commonly used drug classes (with the notable exception of corticosteroids) do not increase the risk of COVID-19-related adverse outcomes. The risk factors for serious complications and death from COVID-19 appear to be similar to those identified in the wider population; those being advanced age, having pre-existing heart or lung disease, and smoking. We recommend that persons with IBD do not alter their course of therapy to avoid complications of COVID-19, though the indiscriminate use of corticosteroids should be avoided. Persons with IBD should follow the same public health recommendations as the general population to reduce their personal risk of acquiring COVID-19.